Fidelity International’s Cellebrite CLBT Stock Holding History

Fidelity International’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.3M	Buy	157,200 +7,200	+5%	+$95.2K	﹤0.01%	766
2026 Q1	$2.07M	Buy	150,000 +30,000	+25%	+$452K	﹤0.01%	768
2025 Q4	$2.16M	Buy	+120,000	New	+$2.15M	﹤0.01%	766
2025 Q2	–	Sell	-95,000	Closed	-$1.85M	–	979
2025 Q1	$1.85M	Sell	95,000 -105,000	-53%	-$2.21M	﹤0.01%	685
2024 Q4	$4.41M	Hold	200,000	–	–	﹤0.01%	614
2024 Q3	$3.37M	Sell	200,000 -5,300	-3%	-$78.6K	﹤0.01%	660
2024 Q2	$2.45M	Buy	205,300 +155,300	+311%	+$1.73M	﹤0.01%	675
2024 Q1	$554K	Buy	+50,000	New	+$510K	﹤0.01%	751

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Fidelity International's CLBT Position: Q2 2026 in Review

Fidelity International increased its Cellebrite (CLBT) stake by 4.8% in Q2 2026, buying an estimated $95.2K and bringing the position to 157,200 shares worth $2.3M. The position accounts for ﹤0.01% of the portfolio, ranked #766.

Fidelity International first reported a position in CLBT in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.41M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

Fidelity International held 157,200 shares of Cellebrite worth $2.3M as of Q2 2026.
Fidelity International bought 7,200 Cellebrite shares in Q2 2026, an estimated $95.2K.
Cellebrite made up ﹤0.01% of Fidelity International's portfolio in Q2 2026, its #766 holding.
Fidelity International first reported a position in Cellebrite in Q1 2024 and has held it in 8 quarters since.
Fidelity International's Cellebrite position peaked at $4.41M in Q4 2024.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.